EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access

Development and Inter‐Laboratory Validation of Multiplex Flow Cytometry Assay for Autoimmune Nodopathy

Young Gi Min iD, Paula Llarch, Cinta Lleixà, Woohee Ju iD, Ha Young Shin iD, Jae Jun Ban, Luis Querol iD, Jung-Joon Sung iD

Journal of the Peripheral Nervous System · 2026

DOI: 10.1111/jns.70137 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of the Peripheral Nervous System, 2026. Verfasst von Young Gi Min und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Flow Cytometry, Autoantibodies, Autoimmune Diseases of the Nervous System. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea, Fondo de Investigación en Salud, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Autoimmune nodopathies (AN) are a group of rare disorders caused by autoantibodies targeting cell‐adhesion molecules located at the node of Ranvier. Reliable and efficient antibody testing for AN has become essential for optimal care of autoimmune neuropathies. In this study, we developed a multiplex flow cytometry (FCM) assay capable of simultaneously detecting four major AN antibodies and validated its diagnostic performance through inter‐laboratory collaboration.

Methods

Multiplex FCM assay was established using live cell lines stably expressing each of the four AN targets—neurofascin‐155 (NF155), contactin‐1 (CNTN1), contactin‐associated protein 1 (CASPR1), and NF186. Using this assay, we tested 87 serum samples (46 AN, 39 disease controls, and 2 healthy controls) and compared the results with those obtained by enzyme linked immunosorbent assay (ELISA), fixed and/or live cell‐based assay (CBA) conducted at an independent laboratory. IgG4 subclass positivity and autoantibody titers were also analyzed and compared between multiplex FCM assay and ELISA.

Results

Multiplex FCM assay demonstrated excellent diagnostic performance, with overall sensitivity of 95.1%, specificity of 97.8%, and accuracy of 99.6%. IgG4 subclass was detected in approximately 80% of AN sera, showing high concordance with ELISA. Antibody titers showed positive correlations between ELISA end‐point titers and FCM‐derived fluorescence intensity values.

Conclusions

This multiplex FCM assay enables rapid, objective, and quantitative detection of AN autoantibodies and the presence of IgG4 subclass using minimal sample volume. High sensitivity and specificity support its potential utility for routine serological testing for AN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Flow CytometryAutoantibodiesAutoimmune Diseases of the Nervous SystemHumansFemaleCell Adhesion MoleculesEnzyme-Linked Immunosorbent AssaySensitivity and SpecificityNerve Growth Factors

Stichwörter der Autor:innen

CIDPELISAautoimmune nodopathycell‐based assaymultiplex flow cytometry assay

Substanzen

AutoantibodiesCell Adhesion MoleculesNerve Growth FactorsNFASC protein, human

Autor:innen und Institutionen

  • Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Young Gi Min, Woohee Ju, Ha Young Shin, Luis Querol, Jung-Joon Sung

Förderung

  • National Research Foundation of Korea
  • Fondo de Investigación en Salud
  • Instituto de Salud Carlos III

Zitieren

APA

Min, Y. G., Llarch, P., Lleixà, C., Ju, W., Shin, H. Y., Ban, J. J., Querol, L., & Sung, J. J. (2026). Development and Inter‐Laboratory Validation of Multiplex Flow Cytometry Assay for Autoimmune Nodopathy. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.70137

Vancouver

Min YG, Llarch P, Lleixà C, Ju W, Shin HY, Ban JJ, et al. Development and Inter‐Laboratory Validation of Multiplex Flow Cytometry Assay for Autoimmune Nodopathy. Journal of the Peripheral Nervous System. 2026. doi:10.1111/jns.70137

BibTeX
@article{Min2026,
  author = {Min, Young Gi and Llarch, Paula and Lleixà, Cinta and Ju, Woohee and Shin, Ha Young and Ban, Jae Jun and Querol, Luis and Sung, Jung-Joon},
  title = {Development and Inter‐Laboratory Validation of Multiplex Flow Cytometry Assay for Autoimmune Nodopathy},
  journal = {Journal of the Peripheral Nervous System},
  year = {2026},
  doi = {10.1111/jns.70137}
}
Kostenlos starten →